Cargando…

A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study

Objective. To evaluate a multi-biomarker disease activity (MBDA) score, a novel index based on 12 serum proteins, as a tool to guide management of RA patients. Methods. A total of 125 patients with RA from the Behandel Strategieën study were studied. Clinical data and serum samples were available fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirata, Shintaro, Dirven, Linda, Shen, Yijing, Centola, Michael, Cavet, Guy, Lems, Willem F., Tanaka, Yoshiya, Huizinga, Thomas W. J., Allaart, Cornelia F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685330/ https://www.ncbi.nlm.nih.gov/pubmed/23392591 http://dx.doi.org/10.1093/rheumatology/kes362

Ejemplares similares

Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study
por: Markusse, Iris M., et al.
Publicado: (2015)

Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial
por: van der Pol, Joy Ardjuna, et al.
Publicado: (2023)

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
por: Markusse, Iris M., et al.
Publicado: (2015)

Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial
por: Akdemir, G, et al.
Publicado: (2016)

Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis
por: Markusse, Iris M, et al.
Publicado: (2014)

Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis
por: Dirven, Linda, et al.
Publicado: (2012)

Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?
por: Bergstra, Sytske Anne, et al.
Publicado: (2020)

Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2014)

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis
por: van Ouwerkerk, Lotte, et al.
Publicado: (2023)

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study
por: Bakker, Marije F, et al.
Publicado: (2012)

Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment
por: Heckert, Sascha L, et al.
Publicado: (2023)

Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis
por: Akdemir, Gülşah, et al.
Publicado: (2018)

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
por: Curtis, Jeffrey R, et al.
Publicado: (2012)

The Influence of Reducing Disease Activity Score on Cervical Spine Deformity in Rheumatoid Arthritis: A Systematic Review
por: Veldman, Anna B., et al.
Publicado: (2022)

Age affects joint space narrowing in patients with early active rheumatoid arthritis
por: Matthijssen, X M E, et al.
Publicado: (2016)

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis
por: Güler-Yüksel, Melek, et al.
Publicado: (2010)

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression
por: van der Helm-van Mil, Annette H. M., et al.
Publicado: (2013)

Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis
por: ter Wee, Marieke M., et al.
Publicado: (2016)

Rheumatoid arthritis
por: Tanaka, Yoshiya
Publicado: (2020)

Earlier chronotype in patients with rheumatoid arthritis
por: Habers, G. Esther A., et al.
Publicado: (2021)

Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
por: Centola, Michael, et al.
Publicado: (2013)

Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide
por: Raterman, Hennie G., et al.
Publicado: (2019)

Correction to: Earlier chronotype in patients with rheumatoid arthritis
por: Habers, G. Esther A., et al.
Publicado: (2021)

Does denosumab not only prevent fractures, but also bone erosions in rheumatoid arthritis?
por: Marsman, Anneke F, et al.
Publicado: (2022)

Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab
por: Hirata, Shintaro, et al.
Publicado: (2015)

Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry
por: Bergstra, Sytske Anne, et al.
Publicado: (2019)

Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis
por: Bergstra, Sytske Anne, et al.
Publicado: (2015)

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study
por: Hirata, Shintaro, et al.
Publicado: (2013)

Current concepts in the management of rheumatoid arthritis
por: Tanaka, Yoshiya
Publicado: (2016)

Rheumatologists’ adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission
por: Akdemir, G., et al.
Publicado: (2016)

Measurement of stiffness in patients with rheumatoid arthritis in low disease activity or remission: a systematic review
por: van Tuyl, Lilian HD, et al.
Publicado: (2014)

Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis
por: Bergstra, Sytske Anne, et al.
Publicado: (2017)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis
por: Derksen, Veerle F A M, et al.
Publicado: (2022)

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
por: de Moel, Emma C., et al.
Publicado: (2019)

Signal transduction inhibitors for the treatment of rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2012)

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes
por: de Moel, Emma C., et al.
Publicado: (2018)

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
por: Amkreutz, Josephine A. M. P., et al.
Publicado: (2021)

Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview
por: Tanaka, Yoshiya
Publicado: (2021)

Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count
por: Hartman, Linda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9s819nnlv72m13rhm235k12ro6